C3a |
C3aR |
Anaphylatoxin (can cause smooth muscle contraction, vasodilation and increased histamine release by mast cells), CD4+ T cell activation, monocyte activation (via NLRP3 inflammasome) cancer progression (direct or indirect effect) |
[63, 65, 147] |
C4a |
PAR1, PAR4 |
Anaphylatoxin |
[169] |
C5a |
C5aR1, C5aR2 |
Anaphylatoxin, NLRP3 inflammasome activation in CD4+ T cells and monocytes, regulates cancer progression |
[66] |
C3b |
CD46, FH, CR1 |
Opsonin (via its receptors), part of the C3 and C5 convertases, activates CD4 T cells in autocrine fashion |
[61] |
Factor H (FH) |
None, binds to Factor I and C3b or cell surface |
In complex with the serine protease factor I, cleave and inactivate C3b to iC3b |
[170] |
CD46 |
None, binds to C3b, C4b and Factor I |
In complex with the serine protease factor I, cleave and inactivate C3b (or C4b) to iC3b, potent costimulatory molecule on CD4+ T cell activation and metabolism |
[61, 62, 73] |
Complement receptor 1 (CR1, CD35) |
None, binds to C3b, iC3b |
cleaves iC3b to C3dg, mediates inhibitory signals in T cell proliferation |
[171] |
Complement receptor 2 (CR2, CD21) |
None, binds the degradation products of C3b (iC3b, C3dg, C3d) |
Potent costimulatory molecule in B cells. Also controls survival (CR1) of germinal center B cells during development |
[172–174] |
Complement receptor 3 (CR3 or CD11b/CD18, or Mac-1) |
None, binds iC3b |
Opsonizes iC3b coated bacteria |
[28, 175] |
Complement receptor 4 (CR4 or CD11c/CD18) |
None, binds to different part of iC3b than CR3 |
Opsonizes iC3b coated bacteria |
[28, 175] |